KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Esperion Therapeutics (ESPR) Depreciation & Amortization (CF): 2018-2025

Historic Depreciation & Amortization (CF) for Esperion Therapeutics (ESPR) over the last 8 years, with Sep 2025 value amounting to $26,000.

  • Esperion Therapeutics' Depreciation & Amortization (CF) changed negligibly% to $26,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $143,000, marking a year-over-year increase of 37.50%. This contributed to the annual value of $100,000 for FY2024, which is 50.00% down from last year.
  • As of Q3 2025, Esperion Therapeutics' Depreciation & Amortization (CF) stood at $26,000, which was down 3.70% from $27,000 recorded in Q2 2025.
  • Esperion Therapeutics' 5-year Depreciation & Amortization (CF) high stood at $153,000 for Q1 2021, and its period low was $10,000 during Q2 2024.
  • Over the past 3 years, Esperion Therapeutics' median Depreciation & Amortization (CF) value was $26,500 (recorded in 2023), while the average stood at $37,900.
  • Per our database at Business Quant, Esperion Therapeutics' Depreciation & Amortization (CF) slumped by 80.39% in 2024 and then surged by 170.00% in 2025.
  • Esperion Therapeutics' Depreciation & Amortization (CF) (Quarterly) stood at $153,000 in 2021, then plummeted by 39.87% to $92,000 in 2022, then plummeted by 54.35% to $42,000 in 2023, then surged by 52.38% to $64,000 in 2024, then remained steady at $26,000 in 2025.
  • Its Depreciation & Amortization (CF) stands at $26,000 for Q3 2025, versus $27,000 for Q2 2025 and $26,000 for Q1 2025.